Related Experiment Video
Updated: Jun 9, 2025
07:16
In Vivo Assessment of Rodent Plasmodium Parasitemia and Merozoite Invasion by Flow Cytometry
Published on: April 5, 2015
10.0K
Leveraging the Aggregated Protein Dye YAT2150 for Malaria Chemotherapy
Claudia Camarero-Hoyos1,2,3, Inés Bouzón-Arnáiz1,2, Yunuen Avalos-Padilla1,2
1Barcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Rosselló 149-153, 08036 Barcelona, Spain.
Pharmaceutics
|October 26, 2024
Summary
YAT2150 shows promise as a novel antimalarial drug and diagnostic tool. This compound targets Plasmodium parasites, inhibiting their development and transmission, with potential for malaria diagnosis and therapy.
Area of Science:
- Medicinal Chemistry
- Parasitology
- Drug Discovery
Background:
- YAT2150 is a novel antiplasmodial compound with potential for malaria therapy.
- Its fluorescence properties suggest applications in sensitive diagnostic approaches.
Purpose of the Study:
- To investigate the therapeutic and diagnostic potential of YAT2150.
- To elucidate its mechanism of action and pharmacokinetic profile.
Main Methods:
- In vitro studies on Plasmodium development and mosquito transmission.
- Cellular uptake and efflux studies in Caco-2 cells.
- Drug metabolism and pharmacokinetic profiling.
- Analysis of YAT2150 interaction with amyloid-forming peptides and protein aggregates.
Main Results:
- YAT2150 inhibits Plasmodium ookinete development and mosquito oocyst formation, indicating transmission-blocking potential.
- The compound is internalized via endocytosis and OATP2B1, with OSTα as a primary export route.
- YAT2150 exhibits a favorable pharmacokinetic profile and reduced cytotoxicity when encapsulated in immunoliposomes.
- The drug preferentially binds to unstructured protein aggregates within Plasmodium, reducing protein aggregation.
Conclusions:
- YAT2150 represents a new class of compounds for malaria diagnosis and therapy.
- Its novel mechanism of action involves interaction with functional protein aggregates in Plasmodium.
- YAT2150 holds promise for both therapeutic intervention and diagnostic development in malaria control.
